Survival Analysis: From Square One to Square Two Yin Bun Cheung, Ph.D. Paul Yip, Ph.D. Readings.

Slides:



Advertisements
Similar presentations
The analysis of survival data in nephrology. Basic concepts and methods of Cox regression Paul C. van Dijk 1-2, Kitty J. Jager 1, Aeilko H. Zwinderman.
Advertisements

COMPUTER INTENSIVE AND RE-RANDOMIZATION TESTS IN CLINICAL TRIALS Thomas Hammerstrom, Ph.D. USFDA, Division of Biometrics The opinions expressed are those.
Residuals Residuals are used to investigate the lack of fit of a model to a given subject. For Cox regression, there’s no easy analog to the usual “observed.
Surviving Survival Analysis
Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
Survival Analysis In many medical studies, the primary endpoint is time until an event occurs (e.g. death, remission) Data are typically subject to censoring.
If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.
Introduction to Survival Analysis October 19, 2004 Brian F. Gage, MD, MSc with thanks to Bing Ho, MD, MPH Division of General Medical Sciences.
Departments of Medicine and Biostatistics
HSRP 734: Advanced Statistical Methods July 24, 2008.
Introduction Cure models within the framework of flexible parametric survival models T.M-L. Andersson1, S. Eloranta1, P.W. Dickman1, P.C. Lambert1,2 1.
April 25 Exam April 27 (bring calculator with exp) Cox-Regression
Chapter 11 Survival Analysis Part 3. 2 Considering Interactions Adapted from "Anderson" leukemia data as presented in Survival Analysis: A Self-Learning.
Chapter 11 Survival Analysis Part 2. 2 Survival Analysis and Regression Combine lots of information Combine lots of information Look at several variables.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Model Checking in the Proportional Hazard model
Assessing Survival: Cox Proportional Hazards Model Peter T. Donnan Professor of Epidemiology and Biostatistics Statistics for Health Research.
Analysis of Complex Survey Data
Survival Analysis: From Square One to Square Two
Survival analysis Brian Healy, PhD. Previous classes Regression Regression –Linear regression –Multiple regression –Logistic regression.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 10: Survival Curves Marshall University Genomics Core.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
1 Survival Analysis Biomedical Applications Halifax SAS User Group April 29/2011.
HSRP 734: Advanced Statistical Methods July 10, 2008.
G Lecture 121 Analysis of Time to Event Survival Analysis Language Example of time to high anxiety Discrete survival analysis through logistic regression.
Dr Laura Bonnett Department of Biostatistics. UNDERSTANDING SURVIVAL ANALYSIS.
Biostatistics Case Studies 2005 Peter D. Christenson Biostatistician Session 4: Taking Risks and Playing the Odds: OR vs.
1 Introduction to medical survival analysis John Pearson Biostatistics consultant University of Otago Canterbury 7 October 2008.
Assessing Survival: Cox Proportional Hazards Model
Design and Analysis of Clinical Study 11. Analysis of Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Use of FP and Other Flexible Methods to Assess Changes in the Impact of an exposure over time Willi Sauerbrei Institut of Medical Biometry and Informatics.
INTRODUCTION TO SURVIVAL ANALYSIS
Chapter 12 Survival Analysis.
01/20151 EPI 5344: Survival Analysis in Epidemiology Survival curve comparison (non-regression methods) March 3, 2015 Dr. N. Birkett, School of Epidemiology,
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
Survival Analysis 1 Always be contented, be grateful, be understanding and be compassionate.
Lecture 12: Cox Proportional Hazards Model
01/20151 EPI 5344: Survival Analysis in Epidemiology Cox regression: Introduction March 17, 2015 Dr. N. Birkett, School of Epidemiology, Public Health.
Statistics for Neurosurgeons A David Mendelow Barbara A Gregson Newcastle upon Tyne England, UK.
1 Using dynamic path analysis to estimate direct and indirect effects of treatment and other fixed covariates in the presence of an internal time-dependent.
Treat everyone with sincerity,
INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
Carolinas Medical Center, Charlotte, NC Website:
ANZDATA Epidemiology Fellow
Applied Biostatistics: Lecture 4
BIOST 513 Discussion Section - Week 10
An introduction to Survival analysis and Applications to Predicting Recidivism Rebecca S. Frazier, PhD JBS International.
Comparing Cox Model with a Surviving Fraction with regular Cox model
April 18 Intro to survival analysis Le 11.1 – 11.2
Survival Analysis Rick Chappell, Ph.D. Professor,
Survival curves We know how to compute survival curves if everyone reaches the endpoint so there is no “censored” data. Survival at t = S(t) = number still.
Applied Biostatistics: Lecture 2
Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,
Statistics.
Clinical outcome after SVR: Veterans Affairs
Meta-analysis of joint longitudinal and event-time outcomes
Statistical Inference for more than two groups
Statistics 103 Monday, July 10, 2017.
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Statistics 262: Intermediate Biostatistics
If we can reduce our desire,
Biostatistics Primer: What a Clinician Ought to Know: Hazard Ratios
Enrollment and Outcomes
Treat everyone with sincerity,
Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:
Nazmus Saquib, PhD Head of Research Sulaiman AlRajhi Colleges
Kaplan-Meier survival curves and the log rank test
Presentation transcript:

Survival Analysis: From Square One to Square Two Yin Bun Cheung, Ph.D. Paul Yip, Ph.D. Readings

Lecture structure Basic concepts Kaplan-Meier analysis Cox regression Computer practice

What’s in a name? time-to-event data failure-time data censored data (unobserved outcome)

Types of censoring – loss to follow-up during the study period – study closure

Examples of survival analysis 1. Marital status & mortalitymortality 2. Medical treatments & tumor recurrence & mortality in cancer patientstumor recurrence & mortality 3. Size at birth & developmental milestones in infantsdevelopmental milestones

Why survival analysis ? Censoring (time of event not observed) Unequal follow-up time

What is time? What is the origin of time? In epidemiology: Age (birth as time 0) ? Calendar time since a baseline survey ?

What is the origin of time? In clinical trials: Since randomisation ? Since treatment begins ? Since onset of exposure ?

The choice of origin of time Onset of continuous exposure Randomisation to treatment Strongest effect on the hazard

Types of survival analysis 1. Non-parametric method Kaplan-Meier analysis 2. Semi-parametric method Cox regression 3. Parametric method

Square 1 to square 2 This lecture focuses on two commonly used methods Kaplan-Meier method Cox regression model

KM survival curve * d=death, c=censored, surv=survival

KM survival curve

No. of expected deaths Expected death in group A at time i, assuming equality in survival: E Ai =no. at risk in group A i  death i total no. at risk i Total expected death in group A: E A =  E Ai

Log rank test A comparison of the number of expected and observed deaths. The larger the discrepancy, the less plausible the null hypothesis of equality.

An approximation The log rank test statistic is often approximated by X 2 = (O A -E A ) 2 /E A + (O B -E B ) 2 /E B, where O A & E A are the observed & expected number of deaths in group A, etc.

Proportional hazard assumption Log rank test preferred (PH true ) Breslow test preferred (non-PH)

Risk, conditional risk, hazard

Another look of PH Log rank test preferred (PH true ) Breslow test preferred (non-PH) Hazard Time Hazard Time

Cox regression model Handles  1 exposure variables. Covariate effects given as Hazard Ratios. Semi-parametric: only assumes proportional hazard.

Cox model in the case of a single variable 1. h i (t) = h B (t)  exp(BX i ) 2. h j (t) = h B (t)  exp(BX j ) 3. h i (t)/h j (t) =exp[B(X i -X j )]  exp(B) is a Hazard Ratio

Test of proportional hazard assumption Scaled Schoenfeld residuals Grambsch-Therneau test Test for treatment  period interaction Example: mortality of widowsmortality of widows

Computer practice A clinical trial of stage I bladder tumor Thiotepa vs Control Data from StatLibStatLib

Data structure Two most important variables: Time to recurrence (>0) Indicator of failure/censoring (0=censored; 1=recurrence) (coding depends on software)

KM estimates Thiotepa Control

Log rank test chi2(1) = 1.52 Pr>chi2 = 0.22

Cox regression models

Test of PH assumption Grambsch-Therneau test for PH in model II Thiotepa P=0.55 Number of tumor P=0.60

Major References (Examples) Ex 1. Cheung. Int J Epidemiol 2000;29:93-99.Int J Epidemiol Ex 2. Sauerbrei et al. J Clin Oncol 2000;18: J Clin Oncol Ex 3. Cheung et al. Int J Epidemiol 2001;30:66-74.Int J Epidemiol

Major References (General) Allison. Survival Analysis using the SAS ® System. Collett. Modelling Survival Data in Medical Research. Fisher, van Belle. Biostatistics: A Methodology for the Health Sciences.